Literature DB >> 11110063

A case for addressing cigarette use in methadone and other opioid treatment programs.

K P Richter1, J S Ahluwalia.   

Abstract

Most persons attending drug treatment smoke cigarettes. They will eventually experience predictable, but devastatingly high, tobacco-related mortality. Recent studies indicate that many clients are ready to quit smoking and that quitting does not threaten progress made in treatment. Methadone and other opioid treatment providers are in an excellent position to address tobacco use among their clients. The present paper describes the prevalence of smoking among methadone clients, reviews promising interventions, and describes how programs can implement a systematic approach to smoking cessation that includes creating a cue system for identifying smokers, providing brief on-site intervention, and arranging follow-up or more intensive treatment.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11110063     DOI: 10.1300/J069v19n04_04

Source DB:  PubMed          Journal:  J Addict Dis        ISSN: 1055-0887


  14 in total

1.  How is tobacco treatment provided during drug treatment?

Authors:  Jamie J Hunt; A Paula Cupertino; Susan Garrett; Peter D Friedmann; Kimber P Richter
Journal:  J Subst Abuse Treat       Date:  2011-08-09

2.  Understanding the drug treatment community's ambivalence towards tobacco use and treatment.

Authors:  Kimber P Richter; Jamie J Hunt; A Paula Cupertino; Susan Garrett; Peter D Friedmann
Journal:  Int J Drug Policy       Date:  2012-01-26

3.  Staff commitment to providing tobacco dependence in drug treatment: Reliability, validity, and results of a national survey.

Authors:  Jamie J Hunt; A Paula Cupertino; Byron J Gajewski; Yu Jiang; Telmo M Ronzani; Kimber P Richter
Journal:  Psychol Addict Behav       Date:  2013-10-14

4.  Nicotine Increases Codeine Analgesia Through the Induction of Brain CYP2D and Central Activation of Codeine to Morphine.

Authors:  Douglas M McMillan; Rachel F Tyndale
Journal:  Neuropsychopharmacology       Date:  2015-01-29       Impact factor: 7.853

5.  Smoking in pregnant women screened for an opioid agonist medication study compared to related pregnant and non-pregnant patient samples.

Authors:  H E Jones; S H Heil; K E O'Grady; P R Martin; K Kaltenbach; M G Coyle; S M Stine; P Selby; A M Arria; G Fischer
Journal:  Am J Drug Alcohol Abuse       Date:  2009       Impact factor: 3.829

6.  Cigarette use is increasing among people with illicit substance use disorders in the United States, 2002-14: emerging disparities in vulnerable populations.

Authors:  Andrea H Weinberger; Misato Gbedemah; Melanie M Wall; Deborah S Hasin; Michael J Zvolensky; Renee D Goodwin
Journal:  Addiction       Date:  2017-12-19       Impact factor: 6.526

Review 7.  A review of epidemiologic research on smoking behavior among persons with alcohol and illicit substance use disorders.

Authors:  Andrea H Weinberger; Allison P Funk; Renee D Goodwin
Journal:  Prev Med       Date:  2016-05-16       Impact factor: 4.018

8.  Cigarette smoking among opioid-dependent clients in a therapeutic community.

Authors:  JongSerl Chun; Nancy A Haug; Joseph R Guydish; James L Sorensen; Kevin Delucchi
Journal:  Am J Addict       Date:  2009 Jul-Aug

9.  A comparison of cigarette smoking profiles in opioid-dependent pregnant patients receiving methadone or buprenorphine.

Authors:  Margaret S Chisolm; Heather Fitzsimons; Jeannie-Marie S Leoutsakos; Shauna P Acquavita; Sarah H Heil; Molly Wilson-Murphy; Michelle Tuten; Karol Kaltenbach; Peter R Martin; Bernadette Winklbaur; Lauren M Jansson; Hendrée E Jones
Journal:  Nicotine Tob Res       Date:  2013-01-03       Impact factor: 4.244

10.  Characterizing smoking, cessation services, and quit interest across outpatient substance abuse treatment modalities.

Authors:  Erin A McClure; Shauna P Acquavita; Kelly E Dunn; Kenneth B Stoller; Maxine L Stitzer
Journal:  J Subst Abuse Treat       Date:  2013-08-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.